Welcome
Our laboratory aims to decode the epigenome, how genetic information is read, in physiology and diseases. We combine molecular tool development with genetic and genomic approaches to explore epigenetic mechanisms underlying normal physiological functions, and to uncover the epigenetic basis of diseases to accelerate the development of therapeutics. We mainly use human ESC- or iPSC-based system and genetically engineered mouse models to tackle these questions.
Members
X. Shawn Liu, PhD Principal Investigator
PyroMark Sequencer Lab Equipment
Maxwell Two Lab Equipment
Xiaonan Guan, PhD Postdoc
Luis Flores, PhD Postdoc
Xinyue (Tracy) Chen Graduate Student
Minglu Wang Alumni | Undergraduate 2020
Alexa Michel Alumni | Undergraduate 2020
Junming Qian Graduate Student
Richard Pan MD-PhD Student
Liana Dawson Alumni | Undergraduate 2021
Bryan Uceda-Alvarez Undergraduate
Ji-Hyun Hwang, PhD Postdoc
Rachel Gonzalez, PhD Postdoc
Kitti Rusznák Alumni | Visiting PhD Student 2022
Leslie Yao Undergraduate
Jingwei (Jannie) Ren DO Medical Student
Kehan Yi Undergraduate
Jianxiang (Tom) Ye Rotation Student
Publications
-
Qian, J., Guan, X., Xie, B., Xu, C., Niu, J., Tang, X., Li, C.H., Colecraft, H.M., Jaenisch, R. Liu, X.S. (2022). Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons. bioRxiv. (under review in Science)
- Krzisch, M.A., Wu, H., Yuan, B., Whitfield, T.W., Liu, X.S., Fu, D., Garrett-Engele, C.M., Chang, A.N., Warren, S., Cacace, A., Andrykovich, K.R., Rietjens, R.G.J., Jain, B., Wallace, O., and Jaenisch, R. (2022). Fragile X syndrome patient-derived neurons developing in the mouse brain show FMR1 -dependent phenotypes. bioRxiv. https://www.biorxiv.org/content/10.1101/2021.09.27.461739v1 (accepted in Biological Psychiatry)
-
Shpokayte, M., McKissick, O., Guan, X., Yuan, B., Rahsepar, B., Fernandez, F., Ruesch, E., Grella, S.L., White, J.A., Liu, X.S.*, Ramirez, S.* (2022). Hippocampal cells segregate positive and negative engrams. (*co-corresponding author). Nature Communication Biology. 5, Article number: 1009. PDF

- Li C.H., Coffey E.L., Dall’Agnese A., Hannett N.M., Tang X., Henninger J.E., Platt J.M., Oksuz O., Zamudio A.V., Afeyan L.K., Schuijers J., Liu X.S., Markoulaki S., Lungjangwa T., LeRoy G., Svoboda D.S., Wogram E., Lee T.I., Jaenisch R., Young, R.A. (2020). MeCP2 links heterochromatin condensates and neurodevelopmental disease. Nature. PDF

Publications before 2020 - Liu, X.S., Jaenisch, R. (2019). Editing the Epigenome to Tackle Brain Disorders. Trends in Neurosciences. (Invited Review) PDF
- Tang, X., Drotar, J., Li, K., Brumm, S.A., Wu, H., Liu, X.S., Wang, J., Gray, N., Sur, M., Jaenisch, R. (2019). Identification of KCC2 Expression Enhancer Compounds as a Basis for Treatment of Rett Syndrome. Science Translational Medicine. 11 (503) PDF
- Liu, X.S., Wu, H., Krzisch, M., Wu, X., Graef, J., Muffat, J., Hnisz, D., Li, C.H., Yuan, B., Vershkov, D., Cacace. A., Young, R.A., and Jaenisch, R. (2018). Rescue of Fragile X syndrome by DNA methylation editing of the FMR1. Cell. 173, 1-14. (Highlighted by Nature Reviews Neuroscience and Nature Reviews Drug Discovery) PDF
- Liu, X.S., Wu, H., Ji, X., Stelzer, Y., Wu, X., Czauderna, S., Shu, J., Dadon, D., Young, R.A., and Jaenisch, R. (2016). Editing DNA methylation in the mammalian genome. Cell. 167, 233-247. (Highlighted by Nature) PDF
- Lee, J.J., Perera, R.M., Wang, H.*, Wu, D.C.*, Liu, X.S.*, Han, S., Fitamant, J., Jones, P.D., Ghanta, K.S., Kawano, S., Nagle, J.M., Deshpande, V., Boucher, Y., Kato, T., Chen, J.K., Willmann, J.K., Bardeesy, N., Beachy, P.A. (2014). Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc Natl Acad Sci U S A. 111, E3091-3100. (*equal contribution) PDF
- Song, B., Liu, X.S., Rice, S., Elzey, B.D., Konieczny, S.F., Ratliff, T., Hazbun, T., Chiorean, E.G., Liu, X., (2012). Plk1 phosphorylation of Orc2 and Hbo1 contributes to gemcitabine resistance in pancreatic cancer. Molecular Cancer Therapeutics. 12, 58-68. PDF
- Liu, W., Wen, Y., Bi, P., Lai, X., Liu, X.S., Liu, X., Kuang, S. (2012). Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development. 139(16), 2857-65. PDF
- Iliuk, A., Liu, X.S., Xue, L., Liu, X., Tao, W.A. (2012). Chemical Visualization of Phosphoproteomes on Membrane. Mol. Cell Proteomics. 11(9), 629-39. PDF
- Liu, X.S., Song, B., Tang, J., Liu, X. (2012). Plk1 phosphorylates Sgt1 at the kinetochores to promote the timely kinetochore-microtubule attachment. Mol. Cell Biol. 32(19), 4053-67. PDF
- Song B., Liu, X.S., Liu, X. (2012). Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication. Cell Division, 7, 3. (invited review) PDF
- Song, B., Liu, X.S., Davis, K., Liu, X. (2011). Plk1 phosphorylation of Orc2 promotes DNA replication under conditions of stress. Mol. Cell Biol., 31(23), 4844-56. PDF
- Song, B., Davis, K., Liu, X.S., Lee, H.G., Smith, M., Liu, X. (2011). Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer’s disease. Aging, 9, 846-851. PDF
- Liu, X.S., Song, B., Elzey, B.D., Ratliff, T.L., Konieczny, S.F., Cheng, L., Ahmad, N., Liu, X. (2011). Polo-like Kinase 1 Facilitates Loss of Pten Tumor Suppressor-induced Prostate Cancer Formation. J Biol. Chem., 286, 35795-35800. PDF
- Liu, X.S., Liu, X. (2011). Targeting Plk1 in cutaneous T-cell lymphomas (CTCLs). Cell Cycle. 10(10), 1523. (invited commentary) PDF
- Liu, X.S., Song, B., Liu, X. (2011). The substrates of Plk1, beyond the functions in mitosis. Protein & Cell, 11, 999-1010. (invited review) PDF
- Li, H., Liu, X.S. Yang, X., Song, B., Wang, Y., Liu, X. (2010). Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase. Proc Natl Acad Sci USA, 107, 14633-14638. PDF
- Li, H., Liu, X.S. Yang, X., Wang, Y., Wang, Y., Turner, J.R., Liu, X. (2010). Phosphorylation of CLIP-170 by Plk1 and CK2 promotes timely formation of kinetochore-microtubule attachments. EMBO J, 29, 2953-2965. PDF
- Liu, X.S., Li, H., Song, B., Liu, X. (2010). Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery. EMBO Rep, 11, 626-632. PDF
- Yang, X., Li, H., Liu, X.S., Deng, A., Liu, X. (2009). Cdc2-mediated phosphorylation of CLIP-170 is essential for its inhibition of centrosome reduplication. J. Biol. Chem., 284, 28775-28782. PDF
Collaborators
Steve Ramirez, PhD Assistant Professor, Boston U
Xuebing Wu, PhD Assistant Professor, Columbia U
Rudolf Jaenisch, MD Professor, Whitehead Institute | MIT